Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7 - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2015

Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7

Résumé

The human tissue kallikrein-7 (KLK7) is a chymotryptic serine protease member of tissue kallikrein family. KLK7 is involved in skin homeostasis and inflammation. Excess of KLK7 activity is also associated with tumor metastasis processes, especially in ovarian carcinomas, prostatic and pancreatic cancers. Development of Kallikrein 7 inhibitors is thus of great interest in oncology but also for treating skin diseases. Most of the developed synthetic inhibitors present several drawbacks such as poor selectivity and unsuitable physico-chemical properties for in vivo use. Recently, we described a practical sequence for the synthesis of imidazopyridine-fused [1,3]-diazepines. Here, we report the identification of pyrido-imidazodiazepinone core as a new potential scaffold to develop selective and competitive inhibitors of kallikrein–related peptidase 7. Structure-activity relationships (SAR), inhibition mechanisms and selectivity as well as cytotoxicity against selected cancer cell lines were investigated.
Fichier principal
Vignette du fichier
Arama_Pyrido-imidazodiazep.pdf (12.93 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01120269 , version 1 (25-02-2015)

Identifiants

Citer

Dominique P Arama, Feryel Soualmia, Vincent Lisowski, Jean-François Longevial, Elodie Bosc, et al.. Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7. European Journal of Medicinal Chemistry, 2015, 93, pp.202-213. ⟨10.1016/j.ejmech.2015.02.008⟩. ⟨hal-01120269⟩
292 Consultations
254 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More